Immunohistochemical staining of the diagnostic biopsy had shown a MMRd phenotype with a loss of MSH6 protein expression both in the IPMN component and in the carcinoma cells (Fig. 1). This evidence concerns the gene MSH6 and pancreatic intraductal papillary-mucinous neoplasm.